Analysis
PublicANEON BRILLIENT, LLC holds $21.2M across 24 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards in the incumbent pipeline. The prior award was single-bid — competitive dynamics may favor a challenge. Set-aside status: 8AN. PoP ended May 6, 2025 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.
Contract facts
8ANNo full NAICS 518210 intel page yet. Browse NAICS intelligence
DIRECT 8(A) AWARD OF A 3-YEAR, FFP-TYPE PURCHASE ORDER TO EXPAND DEVELOPMENT AND MAINTENANCE OF OCP ANALYSIS-PLATFORM IPORTAL FOR THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF TRANSLATIONAL SCI
Recompete timing
PublicCurrent PoP ended May 6, 2025 (468 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Watch this contract — one email →Incumbent footprint
Public recordANEON BRILLIENT, LLC — $21.2M obligated across 24 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Track this contract
Get an alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
Alert when the recompete window opens, the incumbent changes, or a protest lands. One email, no account.
See all live recompete landscapes — who else is expiring, and where the openings are.
Open ANEON BRILLIENT, LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Frequently asked questions
What is contract 75F40124P00138?
75F40124P00138 (DIRECT 8(A) AWARD OF A 3-YEAR, FFP-TYPE PURCHASE ORDER TO EXPAND DEVELOPMENT AND MAINTENANCE OF OCP ANALYSIS-PLATFORM IPORTAL FOR THE U.S. FOOD AND DRUG ADMINISTRATION (FDA), CENTER FOR DRUG EVALUATION AND RESEARCH (CDER), OFFICE OF TRANSLATIONAL SCI) is a Department of Health and Human Services (HHS) award with an estimated value of $1.1M, currently held by ANEON BRILLIENT, LLC. Figures are USASpending-sourced public-record facts normalized by PrimeRFP SCOUT.
Who is the incumbent on 75F40124P00138?
ANEON BRILLIENT, LLC is the incumbent with $21.2M across 24 related awards in SCOUT’s public footprint. The current period of performance ends May 6, 2025.
When does 75F40124P00138 come up for recompete?
SCOUT tracks a period-of-performance end of May 6, 2025. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →